SIEB vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 16, 2026

SIEB

34.3
AI Score
VS
HIVE Wins

HIVE

46.3
AI Score

Investment Advisor Scores

SIEB

34score
Recommendation
EXTENDED

HIVE

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SIEB HIVE Winner
Forward P/E 38.3142 62.8931 SIEB
PEG Ratio 0.7216 0 Tie
Revenue Growth 109.4% 73.5% SIEB
Earnings Growth -58.0% -99.9% SIEB
Tradestie Score 34.3/100 46.3/100 HIVE
Profit Margin -1.1% -98.5% SIEB
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

SIEB 1M: +5.2% · 3M: +20.1% HIVE 1M: +11.2% · 3M: -29.0%

Current Technical Phase

SIEB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.5 · Price: $2.21

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.1 · Price: $3.48

Fundamentals Snapshot

Metric SIEB HIVE
Market Cap
Forward P/E 38.3 -6.8
Trailing P/E
Revenue (TTM)
Revenue Growth 1.1% 0.7%
Gross Margin 0.9% 0.4%
Operating Margin 0.0% -0.6%
EPS -0.03 -1.39
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.